Free Trial
TSE:FRX

Fennec Pharmaceuticals 8/3/2023 Earnings Report

Fennec Pharmaceuticals logo
C$11.31 +0.21 (+1.89%)
As of 03:50 PM Eastern

Fennec Pharmaceuticals EPS Results

Actual EPS
-C$0.28
Consensus EPS
-C$0.24
Beat/Miss
Missed by -C$0.04
One Year Ago EPS
N/A

Fennec Pharmaceuticals Revenue Results

Actual Revenue
$4.47 million
Expected Revenue
$5.41 million
Beat/Miss
Missed by -$940.00 thousand
YoY Revenue Growth
N/A

Fennec Pharmaceuticals Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Fennec Pharmaceuticals Earnings Headlines

HC Wainwright Analysts Boost Earnings Estimates for TSE:FRX
The most explosive assets in 2025?
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
Wedbush Lifts Earnings Estimates for Fennec Pharmaceuticals
See More Fennec Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fennec Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your email.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals (TSE:FRX) operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

View Fennec Pharmaceuticals Profile

More Earnings Resources from MarketBeat